Esra Merve Zanbak Çotaoğlu

Esra Merve Zanbak Çotaoğlu

Auto-generated profile, based on publicly available information

Esra Merve Zanbak Çotaoğlu

SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, GÜLHANE ECZACILIK FAKÜLTESİ, ECZACILIK TEKNOLOJİSİ BÖLÜMÜ, FARMASÖTİK TEKNOLOJİ ANABİLİM DALI

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2026 in Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Closed access
Yıldırım CesaretliYıldırım Cesaretli
Yıldırım Cesaretli
BEBurcu Eser
Burcu Eser
EÇEsra Merve Zanbak Çotaoğlu
Esra Merve Zanbak Çotaoğlu
KKKübra Kılıç
Kübra Kılıç
An LC–MS/MS procedure was developed and evaluated for measuring vildagliptin in analytical standard solutions, with linagliptin serving as the internal standard. Reference materials dissolved in acetonitrile were used to produce the calibration and quality-control (QC) solutions, and six independently prepared placebo samples were examined for excipient-related interference. An ACE C18 column (50 mm × 2.1 mm, 5 µm) was operated under gradient conditions at 0.3 mL min⁻¹ with 10 mM ammonium acetate and acetonitrile as the aqueous and organic components; each contained 0.01% formic acid. Positive-ion electrospray and multiple-reaction monitoring were used for detection. Across the validated interval of 0.125–4.0 ng mL⁻¹, the calibration model gave R² = 0.9951. Instrumental LOD and LOQ values in the injected solutions were 0.028 and 0.084 ng mL⁻¹, respectively. The highest intra-day or inter-day precision value was 2.15% RSD. At the three QC levels, mean recovery was 99.12–101.7%, and recovery RSD was 2.00–3.29% (n = 6). Each chromatographic cycle lasted 7.5 min. No interfering vildagliptin MRM peak was detected in the placebo preparations, although ion suppression and enhancement were not measured quantitatively. The validation applies to prepared analytical solutions and does not establish performance in dosage forms or biological matrices.

1 January 2024 in Ankara Universitesi Eczacilik Fakultesi Dergisi
Verified
Journal Article
Open access
PDF file
OAOkan Ali AKSOY
Okan Ali AKSOY
EÇEsra Merve Zanbak Çotaoğlu
Esra Merve Zanbak Çotaoğlu
GTGizem Ruya TOPAL
Gizem Ruya TOPAL
BGBerk Alp Göksel
Berk Alp Göksel
OEOzgur Esim
Ozgur Esim
YÖYalçın Özkan
Yalçın Özkan
Amaç: Farklı ilaç uygulamalarının etken maddelerin etkinliğini arttırabildiği bilinmesine rağmen hangi ilaç salım sisteminin daha iyi olduğu konusunda birçok çalışma bulunmaktadır. Bunun nedeninin etken maddenin özelliklerine göre bu uygulamaların daha büyük avantaj sağlamasıdır. Bu çalışmada piroksikam dilaltı polimerik film uygulamasının potansiyel kullanımı araştırılmıştır. Gereç ve Yöntem: Çalışmada piroksikam dilaltı maltodekstrin ve pullulan içeren filmler hazırlanmış ve sağlıklı tavşan in vivo modelinde ilacın plazma düzeyleri araştırılmıştır. Sonuç ve Tartışma: İn vivo sonuçlar, tek doz uygulamadan sonra 10 saat içinde piroksikamın en yüksek plazma konsantrasyonlarına ulaştığını göstermiştir. Ayrıca plazma ilaç profilinde olası gastrointestinal emilime karşılık gelen ikinci bir tepe noktası oluşmamıştır. Özetle, piroksikam yüklü dilaltı polimerik film uygulamasının analjezik etkinin sağlanması amacıyla kullanılabilir özellikte olduğu tespit edilmiştir.

19 May 2026 in Ankara Universitesi Eczacilik Fakultesi Dergisi
Verified
Journal Article
Closed access
OAOkan Ali AKSOY
Okan Ali AKSOY
Tugba Taskin-TokTugba Taskin-Tok
Tugba Taskin-Tok
EÇEsra Merve Zanbak Çotaoğlu
Esra Merve Zanbak Çotaoğlu
NBNurgul Karadas Bakirhan
Nurgul Karadas Bakirhan
EKEngin Kocak
Engin Kocak
YÖYalçın Özkan
Yalçın Özkan
Objective: A simple, rapid, sensitive, and cost-effective high-performance liquid chromatographic (HPLC) method was developed for the pharmacokinetic study and determination of Piroxicam.Material and Method: The chromatographic separation was performed with a Agilent ZORBAX reversed-phase C18 column (250 mm × 4,6 mm ID × 5 μm). Mobile phase composition was 0.04 M KH2PO4: acetonitrile:methanol (50:40:10) at pH 3.8. The flow rate was adjusted as 0.9 mL/min.Result and Discussion: An isocratic method was used for the analysis. The UV detector was set at 360 nm, and a retention time of 7 minutes was obtained for piroxicam. The method showed linear performance over the concentration range of 0.1–4 mg/l.